Investing
Clover Health (CLOV) stock rises on Q3 profit, guidance
Clover Health stock rose 4.3% on November 5, 2026 after a $6 million Q3 profit, 53% revenue growth to $759 million and higher full-year 2026 guidance.
Clover Health stock (CLOV) was up 4.26% in regular trading on November 5, 2026, the session after the Medicare Advantage insurer reported third-quarter results. Clover earned a GAAP net income of $6 million, compared with a $24 million loss a year earlier, and raised its full-year 2026 guidance.
What Clover Health reported
| Metric | Q3 2026 | Q3 2025 | Change |
|---|---|---|---|
| Total revenues | $759.3M | $496.7M | +52.9% |
| Net income (loss) | $6.4M | $(24.4)M | Swing to profit |
| Consolidated gross profit | $129.8M | $73.2M | +77.3% |
| Adjusted EBITDA | $16.1M | $2.1M | +666.7% |
| Average Medicare Advantage members | 158,383 | 108,231 | +46.3% |
Consolidated gross profit is Clover's own measure of earnings before overhead costs. Adjusted EBITDA is profit before interest, taxes, depreciation, stock-based pay and certain one-off items.
Guidance is the company's forecast. Clover raised the low end of each range and kept the top end. Revenue is now expected at $2.97 billion to $3.00 billion, up from $2.92 billion to $3.00 billion. GAAP net income guidance moved to $25 million to $35 million, from $20 million to $35 million. Adjusted EBITDA guidance moved to $75 million to $85 million, from $70 million to $85 million.
The board also made Clay Thornton permanent CFO and named Joseph Oldakowski Chief Accounting Officer, effective November 4.
Why the stock rose 4.3%
The move was about twice a typical day's swing for the stock. The most likely driver was the return to quarterly profit alongside tighter medical costs. The insurance benefits expense ratio, the share of premium revenue paid out in medical claims, fell to 91.1% from 93.5%. That is an improvement of 240 basis points (2.4 percentage points). Clover also said its flagship PPO, which holds about 98% of members, received a 5 Star rating for Payment Year 2028.
What to watch next
-
Clover's presentation at the UBS Global Healthcare Conference on November 9, 2026.
-
Membership results from the 2027 Annual Enrollment Period, which management says is "tracking well."
-
Whether full-year net income lands within the $25 million to $35 million range.
FAQ
Is Clover Health profitable in 2026?
Yes. Net income for the first nine months of 2026 was $61.8 million, against a $36.2 million loss in the same period of 2025. The CFO said Clover expects its first full year of GAAP net income profitability.
How much cash does Clover Health have?
Total cash, cash equivalents and investments were $512.6 million at September 30, 2026. That compares with $395.9 million a year earlier, an increase of 29.5%.
Sources
This article is for information only and is not investment advice.